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Abstract: This study examined the effects of beetroot juice (BTJ) on recovery between two
repeated-sprint tests. In an independent groups design, 20 male, team-sports players were
randomized to receive either BTJ or a placebo (PLA) (2 × 250 mL) for 3 days after an initial repeated
sprint test (20 × 30 m; RST1) and after a second repeated sprint test (RST2), performed 72 h later.
Maximal isometric voluntary contractions (MIVC), countermovement jumps (CMJ), reactive strength
index (RI), pressure-pain threshold (PPT), creatine kinase (CK), C-reactive protein (hs-CRP), protein
carbonyls (PC), lipid hydroperoxides (LOOH) and the ascorbyl free radical (A•−) were measured
before, after, and at set times between RST1 and RST2. CMJ and RI recovered quicker in BTJ compared
to PLA after RST1: at 72 h post, CMJ and RI were 7.6% and 13.8% higher in BTJ vs. PLA, respectively
(p < 0.05). PPT was 10.4% higher in BTJ compared to PLA 24 h post RST2 (p = 0.012) but similar at
other time points. No group differences were detected for mean and fastest sprint time or fatigue
index. MIVC, or the biochemical markers measured (p > 0.05). BTJ reduced the decrement in CMJ
and RI following and RST but had no effect on sprint performance or oxidative stress.
Keywords: beetroot juice; muscle damage; exercise recovery; repeated sprint exercise
1. Introduction
Repeated sprint exercise (RSE), in which a number of short-duration maximal effort sprints (2–6 s)
are completed intermittently with brief recovery periods (≤60 s), places a great deal of stress on
the physiological and musculoskeletal systems [1]. The high energy turnover during RSE induces
significant metabolic stress, triggering rapid perturbations in the nervous, immune, and endocrine
systems [1], as well as an increased formation of reactive oxygen species (ROS) [2]. In addition, the
high-force eccentric muscle contractions required to accelerate and decelerate during RSE places a great
deal of mechanical stress on the musculoskeletal system, particularly the quadriceps and hamstring
muscle groups [3]. It is therefore not surprising that team-sport players, who routinely engage in RSE
in training sessions and matches, often display symptoms of muscle damage (i.e., muscle soreness
and reduced muscle function) that can persist for several days [4–6]. Because the typical time between
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training sessions and or matches is often not sufficient for full recovery (≤72 h) athletes and coaches
are continually seeking strategies that could help minimise the negative effects of muscle damage [7,8].
The exact mechanisms to explain the causes of muscle damage after RSE are not fully
understood, but a host of factors such as muscle membrane damage, sarcomere disorganization,
excitation-contraction coupling dysfunction, contractile protein degradation and inflammation are
all likely to play a role [9,10]. Furthermore, it has been suggested that the generation of ROS in
the days post-exercise, likely a consequence of inflammatory mediated repair processes, might
exacerbate the existing muscle damage by degrading components of the cytosol that are integral
to force production [11–13]. A number of studies have provided evidence of oxidative stress in the
hours and days following RSE [2,6,14], suggesting that the endogenous antioxidant system is unable
to cope with excess ROS production under these conditions. Thus, it would be reasonable to assume
that the prolonged decrement in muscle function might be, at least in part, attributable to oxidative
stress. This also makes the expectation tenable that interventions attempting to combat the excess
production of ROS and control oxidative stress, such as antioxidants, could help accelerate the rate of
muscle recovery following RSE.
While the nutritional antioxidants vitamin C and E have proven largely ineffective at attenuating
muscle damage [15–17], there is growing support for the use of antioxidant-rich fruit and vegetable
beverages as recovery aids [18]. Recently, we showed that supplementation with beetroot juice
(BTJ) attenuated some aspects of muscle damage following high intensity plyometric exercise [19].
We proposed that one of the potential mechanisms by which of BTJ might have attenuated EIMD in this
study was via its antioxidant effects. Although the antioxidant effects of BTJ has received little attention
in the literature, findings from our previous work [20] and others [21,22] suggest that its antioxidant
capacity is markedly higher than other vegetable juices, such as tomato and carrot juice, and also than
several other drinks considered to have a high antioxidant capacity such as green tea, apple, cherry
and cranberry juice [20,23,24]. The high antioxidant capacity of BTJ is due to the fact that several
of the phytonutrient compounds it contains have been shown to scavenge ROS production in vitro
and in vivo and subsequently limit cellular injury [25–27]. The most potent antioxidant molecules in
BTJ are thought to be the betalain pigments, which are responsible for beetroot’s violet colour [28].
The betalains, and betanin in particular, are very effective electron donors that have been shown to
not only attenuate ROS mediated injury but also to upregulate endogenous antioxidant enzymes and
stimulate host defence [29–32]. In addition, BTJ is rich in nitrate, which, via its reduction to nitric oxide
(NO) might have indirect antioxidant effects by supressing the accumulation of leukocytes [33], which
are thought to be the main producers of ROS after muscle-damaging exercise [34]. Nonetheless, we
failed to quantify oxidative stress in our aforementioned experiment [19] to confirm or refute this posit.
Furthermore, the aforementioned findings were in recreationally active participants and therefore
these results might not be directly transferable to better trained athletic populations.
To our knowledge, the effects of BTJ on muscle damage and recovery after activity incorporating
RSE has not been investigated. Additionally, the effectiveness of such an intervention on subsequent
performance has not been considered. Therefore, the main aim of this study was to examine whether
BTJ can attenuate losses in muscle function and performance between two sport-specific repeated
sprint tests (RST) performed 72 h apart. We also examined the effects of BTJ on biochemical markers
associated with muscle damage, specifically oxidative stress, to try and discern what role (if any)
the antioxidant potential of BTJ has on attenuating EIMD. Based on our previous findings [19], we
hypothesized that: (1) BTJ would attenuate muscle function deficits and oxidative stress between and
after the two repeated sprint tests; and (2) that performance during the second sprint test would be
preserved with BTJ compared to a placebo.
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2. Materials and Methods
2.1. Participants
Twenty male participants gave written informed consent for participation in this study
(characteristics presented in Table 1). The sample size for this study was based on a priori power
calculation. Based on a previous study [19], with a power of 0.80 and two tailed α level set at 0.05,
the minimum number of participants required to detect an 8% difference in counter movement jump
(CMJ) performance between groups (SD: 6%) was estimated as 10 per group. We selected CMJ
as our primary outcome measure because it is believed to be the most sensitive test for detecting
reductions in neuromuscular function after RSE [35]. Our secondary outcomes included other markers
of neuromuscular function, repeated sprint performance, muscle pain, and biochemical markers
of inflammation, oxidative stress and muscle damage (specific details in relevant sections below).
All participants were collegiate team-sports players, competing in either soccer (n = 10), rugby
(n = 5), basketball (n = 2) hockey (n = 2) or handball (n = 1) on a regular basis; all testing was
performed at the end of the competitive season (between March 2015 and June 2015). Participant’s
eligibility was assessed with a health screening questionnaire. None had any known food allergies,
were suffering from a musculoskeletal injury, or had previous history of renal, gastrointestinal or
cardiovascular complications or any other contraindication to the study procedures. For the 48 h
prior to and throughout data collection, participants were prohibited from consuming alcoholic
beverages, and instructed to avoid any strenuous exercise outside of the trial requirements. The study
protocol received ethical approval from the Faculty of Health and Life Sciences ethics committee at
Northumbria University. Approval was granted on the 26 February 2015 and assigned the following
project identification code: HLSTC200115.
Table 1. Descriptive data for participants in the beetroot juice (BTJ) and placebo (PLA) groups.
Group Age (Years) Height (m) Mass (kg)
BTJ 23 ± 3 1.83 ± 0.90 76.8 ± 9.5
PLA 21 ± 2 1.77 ± 0.51 73.4 ± 12.4
Values are mean ± SD (n = 10 per group). No significant differences were detected between groups for any
variable (p > 0.05).
2.2. Experimental Design
This study employed a double-blind, placebo controlled, independent groups design. Participants
were required to attend the laboratory for 6 visits over a 2 week period. The first visit was to familiarise
the participants with the study procedures and randomly allocate them to either a beetroot juice
(BTJ) or an isocaloric placebo (PLA) group. Their baseline maximal isometric voluntary contraction
(MIVC) was used to match the groups. The principal investigator was responsible for the randomizing
procedures. The next five visits were performed on consecutive days in the same laboratory at the
same time of day and were preceded by an overnight fast. For the main trials, participants performed
two repeated sprint tests separated by 72 h (visit 2 = RST1 and visit 5 = RST2) (see Figure 1 for
schematic outline). A range of dependent variables were taken pre, 30-min post, 24, 48 and 72 h
after RST1, and 30-min post and 24 h after RST2 to monitor recovery. On each occasion, dependent
variables were performed in the following order: pressure-pain threshold (PPT), venous blood draw,
CMJ, reactive strength index (RI) and MIVC. After completing the post-exercise measures participants
consumed 1 serving of their allocated treatment, and returned to the lab 2.5 h post ingestion for a
further blood sample. Another treatment was taken with an evening meal, and then at the same points
(with breakfast and with an evening meal) for the following 3 days. All data collection took place in
the exercise laboratories at Northumbria University.
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Figure 1. Schematic outline of study procedures.
2.3. Repeated Sprint Test
The RST consisted of 20 maximal-effort 30 m sprints, interspersed by 30 s of passive recovery.
A 10 m deceleration zone was marked out at the end of each 30 m sprint, in which participants
were required to stop within; the 30 s rest period commenced when participants had come to
a halt. The RST was adapted from previous studies that showed repeated sprints with forced
decelerations induce substantial muscle damage and fatigue in team-sport trained participants [3,36,37].
Furthermore, the muscle damage induced by an analogous RST seems to cause reductions in muscle
function not different to those observed after intermittent sport simulations [38] and competitive
matches [39]. Before performing each RST, participants undertook a standardized warm up as
previously described [3]. Briefly, participants completed 400 m of self-selected jogging, a series
of dynamic stretches, and sprints at 60% and 80% of maximal effort. Participants were then given
a further 5 min to complete their own stretching. Timing gates (Brower Timing Systems, Draper,
UT, USA) were positioned at 0 and 30 m to record sprint times. Participants were instructed to give
maximal-effort for each sprint and were provided with strong verbal encouragement throughout.
All testing took place in an air conditioned sprint track in similar environmental conditions.
2.4. Maximal Isometric Voluntary Contractions
MIVC of the right knee extensors was assessed as previously described [3,19]. Participants were
seated and fitted to a portable strain gauge (MIE Medical Research Ltd., Leeds, UK) via a plinth placed
just above the malleoli of the right ankle. In this positon, joint angle was adjusted to 90◦ of knee flexion
using a goniometer and marked to ensure consistency across visits. Participants performed 3 maximal
effort isometric contractions, each lasting 3 s, and separated by 60 s seated rest. The peak value in
Newton’s (N) was used for analysis. Coefficient of variation (CV) for this protocol in our lab was
calculated as 1.1%.
2.5. Counter Movement Jump
CMJ height was determined from flight time using an optical measurement system (Optojump
next, Bolzano, Italy). Participants started the movement upright with hands fixed to their hips and after
a verbal cue, descended into a squat prior to performing a maximal effort vertical jump. Participants
performed 3 maximal efforts, separated by 30 s standing recovery. Mean height (cm) was used for
analysis. The CV for this protocol in our lab was calculated as 2.1%.
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2.6. Reactive Strength Index
Reactive strength index (RI) was used to measure the impact of muscle damaging exercise on
participant’s ability to utilize the stretch shortening cycle and perform explosive actions. In a similar
fashion to previous studies [40], participants performed a drop jump from a 30 cm box and, upon
landing, immediately jumped vertically, with instructions to minimise ground contact time while
maximising jump height. RI was calculated as jump height divided by ground contact time (cm/ms)
recorded from an optical measurement system (Optojump next). Participants performed 3 maximal
efforts separated by 30 s of passive (standing recovery) with the mean height of the 3 jumps used for
analysis. The CV for this protocol was calculated as 1.9% in our lab.
2.7. Treatments and Dietary Control
Participants consumed 2 bottles (250 mL per bottle) of their assigned treatment (BTJ or PLA) on
the day, 24, and 48 h after RST1 and 30-min post RST2, equating to 8 servings in total. One bottle
was consumed 30-min after each trial, and one with an evening meal. The BTJ was supplied by Gs
Fresh Ltd., (Cambridgeshire, UK) and consisted of 99% beetroot juice concentrate, nitrate and other
phytonutrients; specific details of the antioxidant capacity and phytonutrient content of this drink
can be found elsewhere [20]. The PLA consisted of a low fruit containing (<1%) squash (Kia Ora,
Coca Cola Enterprises, Uxbridge, UK), flavourless protein powder (Arla Foods, Amba, Denmark) and
maltodextrin powder (Myprotein, Manchester, UK) providing a negligible amount of phytochemicals
and nitrate. Treatments were closely matched for volume, macro-nutrient and energy content, but
differed in antioxidant capacity and nitrate content (see Table 2). Participants were provided with
food dairies to record their intake 24 h prior to RST1 up until data collection was complete (24 h post
RST2; 5 days in total). Average energy and macronutrient intake for each group is presented in Table 3.
To comply with the double-blind, randomized design, drinks were provided in identically masked
bottles, only distinguished by a single letter code. These were prepared by an individual not involved
in data collection. As detailed in a previous study [19], due to the distinct taste of BTJ, the PLA was not
matched for taste and texture, only energy content. While others have used nitrate depleted BTJ as a
PLA so that the taste is the same, this is not a true PLA because it will still contain many other bioactive
constituents (i.e., phenolics and betalains) that, as outlined in the introduction, could favourably affect
recovery. Thus, this would not have been plausible in the present study. Rather, in an attempt to
overcome this, the participants were not informed of what the specific drinks being investigated were.
The only information they received was that they were antioxidant-containing drinks used for recovery.
This ensured that the participants did not know the overall aim of the study, eliminating any bias based
on pre-conceptions regarding BTJs potential ergogenic effects. Additionally, because we employed an
independent groups design, participants were never aware of the taste/texture of the other treatment
under investigation.
Table 2. Energy and macronutrient content, trolox equivalence antioxidant capacity (TEAC) and nitrate
content of the beetroot juice (BTJ) and placebo (PLA) supplements.
Treatment BTJ PLA
Energy (Kcals) 81 77
Volume (mL) 250 250
Carbohydrate (g) 16.4 16.4
Protein (g) 2.8 2.8
Fat (g) 0.4 Trace
Nitrate (mg) ≥143 Trace
TEAC * (mmol·L−1) 11.4 ± 0.2 0.25 ± 0.02
* Estimation based on previous analyses [20].
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Table 3. Average intake and macro nutrient composition of participants diets (average of 5 days).
Mean Dietary Intake (5 Days)
BTJ PLA
Energy (Kcal) 2554 ± 682 2448 ± 390
Carbohydrates (%) 41 ± 5 43 ± 6
Protein (%) 21 ± 3 24 ± 7
Fat (%) 38 ± 7 33 ± 9
Values are mean ± SD (n = 10 per group). No significant differences were detected between groups for any
variable (p > 0.05).
2.8. Muscle Soreness
Site specific muscle soreness was assessed with a handheld algometer (Wagner Instruments,
Greenwich, CT, USA). A cylindrical flat headed pad (1 cm diameter) was applied with increasing
pressure on the muscle belly at three pre-marked sites: vastus lateralis, mid-way between the superior
aspect of the greater trochanter and head of the tibia, rectus femoris, mid-way between the anterior
patella and inguinal fold, and gastrocnemius, most medial aspect of the calf at relaxed maximum
girth. The point at which the participant signified they felt pain was recorded in N2 as pressure
pain threshold (PPT). Sites were re-marked on each visit to ensure consistency between recordings.
The average of two values from each site was used for analysis, unless the difference between the two
values was >10 N2 apart, in which case a third recording was taken, and the average of the two closest
values used for analysis.
2.9. Blood Sampling
Venous blood was obtained via venepuncture from a branch of the basilica vein at the antecubital
fossa. Samples were collected into di-potassium ethylene diamine tetra-acetic acid (EDTA) (1 × 10 mL)
and serum vacutainers (1 × 10 mL). EDTA tubes were immediately centrifuged at 3000× g (4◦) for
10 min, while serum tubes were allowed to clot for 45 min before centrifugation. Plasma and serum
supernatant was aspirated into a series of aliquots and stored at −80 ◦C for later analysis.
2.10. Biochemical Analysis
High sensitivity C-reactive protein (hs-CRP) and creatine kinase (CK) were measured in serum
using an automated system based on an electrochemiluminescence method (Roche Modular, Roche
Diagnostics, Indianapolis, IN, USA. The typical CV for this method is <2%. Plasma protein carbonyls
were measured using a commercially available assay kit (Cayman Chemical, Ann Arbor, MI, USA).
Lipid hyroperoxides (LOOH) were measured in serum using the ferrous iron/xylenol orange (FOX)
assay (Wolff 1994). The FOX assay determines the susceptibility to iron-induced LOOH formation in
blood; consequently, the presence of iron ions in the assay protocol might lead to slightly higher LOOH
values compared with other methods. Absorbance was read at 560 nm using a spectrophotometer
(U-2001, Hitachi, Berkshire, UK) (range 0–5 µmol·L−1).
Ascorbyl free radical determination was quantified at room temperature using a Bruker EMX
series X-band EPR spectrometer (Bruker, Karlsruhe, Germany). 1 mL of plasma was mixed thoroughly
with 1 mL of dimethyl sulfoxide (DMSO) and slowly flushed into an aqua X multiple bore cavity
cell. The EMX parameter settings were frequency, 9.785 GHz; microwave power, 20 mW; modulation
frequency, 100 kHz and modulation amplitude, 1.194 G. All EPR spectra were subjected to 3 scans
identically filtered and analysed using WinEPR software (Version 3.2, Bruker WinEPR, Coventry, UK).
The average spectral peak-to-trough line amplitude was used to determine free radical concentration.
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2.11. Data Analysis
All data are expressed as mean ± standard deviation (SD) and were analysed using IBM
SPSS Statistics 22 for Windows (Surrey, UK). Participant’s food diaries (5 days) were analysed
for macronutrient content using dietary analysis software (Nutritics LTD, Dublin, Ireland).
Differences between participant group characteristics were analysed with an independent samples
t-test. CMJ, RI, MIVC and PPT were measured using a mixed model ANOVA; 2 group levels (BTJ
vs. PLA) by 7 time levels (pre, post, 24, 48, 72, 73 and 96 h post RST1). The same ANOVA was
use to analyse all blood indices but with 2 additional time levels (2.5 h post RST1 and 2.5 h post
RS2). A separate ANOVA was used to measure for differences between RST1 and RST2; 2 group
levels (BTJ vs. PLA) by 2 time levels (pre and post). In the event of a significant interaction effect
(group * time) Fisher LSD post hoc analysis was performed to locate where the significant differences
occurred. Statistical significance was set at p < 0.05 prior to analyses. To estimate the magnitude of
the supplements effects, Cohen’s d effect sizes (ES) were calculated with the magnitude of effects
considered either small (0.20–0.49), medium (0.50–0.79) and large (>0.80).
3. Results
There were no between group differences in age, height, mass or baseline MIVC strength (Table 1;
p > 0.05), indicating that the groups were well matched prior to testing. Furthermore, there were no
differences in participant’s energy and macronutrient intake 24 h prior to and throughout the duration
of the study (Table 3; p > 0.05). No adverse effects were reported by the participants throughout
the trial.
3.1. Repeated Sprints
RPE showed no bout (p = 0.925) or interaction effects (p = 0.584) between RST1 and RST2,
indicating that perceived exertion was not different for both bouts (Table 4). This was reflected in the
sprint data, as fastest sprint time and fatigue index were not different between repeated sprint bouts,
showing no main effects of time, bout, or bout * group interactions (p > 0.05). No group or group *
bout interaction effects were present (p > 0.05).
Table 4. Sprint and RPE data for the beetroot juice (BTJ) and placebo (PLA) groups in the first and
second repeated sprint tests (RST1 and RST2, respectively).
Group Average Sprint Time (s) Fastest Sprint Time (s) Fatigue Index (%) RPE
BTJ
RST1 4.65 ± 0.25 4.41 ± 0.23 5.60 ± 2.13 15 ± 1
RST2 4.66 ± 0.24 4.38 ± 0.17 6.48 ± 2.66 15 ± 1
PLA
RST1 4.70 ± 0.15 4.48 ± 0.14 4.91 ± 1.51 14 ± 2
RST2 4.77 ± 0.20 4.53 ± 0.15 5.19 ± 3.21 14 ± 2
3.2. Functional Measures
All tests of neuromuscular function (CMJ, MIVC, RI), and PPT, showed main effects for time
(p < 0.05), indicating that the RST induced muscle damage. Immediately post RST1, CMJ height was
reduced by 11.8%± 8.9% and 9.6%± 4.8% (of baseline values) in the BTJ and PLA groups, respectively.
A group effect showed that CMJ height appeared to recover quicker in BTJ vs. PLA throughout the
remainder of the testing period (p = 0.048; Figure 2). Although no group*time interaction effects were
present (p = 0.176), there was a large effect size (1.86) at 72 h post RST1 whereby CMJ height in the
BTJ group was 7.6% higher than the PLA group. A group effect for RI (p = 0.030) showed that the
maintenance of RI performance was also greater in BTJ vs. PLA throughout the trial (Figure 3). As with
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CMJ, a large effect size (1.43) was evident at 72 h post RST1 where RI had returned to 95.8% ± 9.5%
of baseline values in BTJ compared to 82% ± 9.5% in PLA. There were no group effects for PPT
(p = 0.368); however, an interaction effect was observed (p = 0.013; Figure 4). Post-hoc analysis revealed
a group difference at 96 h post RST1 (p = 0.012; ES = 0.57); in the BTJ group, PPT had recovered to
104.7% ± 12.5% of baseline values, while in the PLA group, PPT was 94.3% ± 18% of baseline values.
There were no significant group or interaction effects for MIVC (p > 0.05).
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Figure 2. Percentage changes in counter movement jump (CMJ) height between repeated sprint tests 
(RST1 and RST2).  * Represents group difference  (beetroot  juice  (BTJ) vs. placebo  (PLA); p < 0.05). 
Values are mean ± SD (n = 10 per group). 
 
Figure 3. Percentage changes in reactive strength index (RI) between repeated sprint tests (RST1 and 
RST2).  * Represents group difference  (beetroot  juice  (BTJ) vs. placebo  (PLA); p < 0.05). Values are 
mean ± SD (n = 10 per group). 
Figure 3. P rc ntage changes in active streng h index (RI) between repeated s rint tests (RST1 and
RST2). * Represents group difference (beetroot juice (BTJ) vs. placebo (PLA); p < 0.05). Values are
mean ± SD (n = 10 per group).
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Figure 4. Percentage changes in pressure pain threshold (PPT) between repeated sprint tests (RST1
and RST2). Values presented are average of the three sites measured (calf (CF), rectus femoris (RF) and
vastus laterialis (VL). * Indicates interaction effect (beetroot juice (BTJ) vs. placebo (PLA); p < 0.05).
Values are mean ± SD (n = 10 per group).
3.3. Biochemical Indices
Serum concentrations of hs-CRP remained close to baseline values throughout the trial, showing
no time, group or interaction effects (p > 0.05). Serum CK showed main effects for time (p < 0.001),
with the greatest increases observed 2.5 and 24 h post RST1 and RST2 in both groups (p > 0.05; Table 5).
However, no group of interaction effects were observed (p > 0.05). A main effect for time was observed
for serum LOOH (p < 0.001); LOOH was elevated immediately and at 2.5 h post-RST1 in both groups
before returning to baseline 24 h post. A transient increase in LOOH was also evident at 75 h (2.5 h post
RST2) but by 96 h had recovered to pre-exercise values. No group or interaction effects were present
for LOOH (p > 0.05). Protein carbonyls, a common measure of protein oxidation, remained largely
unchanged after both sprint bouts and showed no group or interaction effects (p > 0.05). Likewise, A•−,
as measured by EPR, showed no time, group or interaction effects throughout the trial (p > 0.05).
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Table 5. Maximal isometric voluntary contractions (MIVC), high sensitivity-C-reactive protein (hs-CRP), creatine kinase (CK), lipid hydroperoxides (LOOH), protein
carbonyls (PC) and plasma ascorbate free radical (A•−) for the beetroot juice (BTJ) and placebo (PLA) group’s pre-RST1 (0 h)—96 h post.
0 h 1 h 2.5 h 24 h 48 h 72 h 73 h 75.5 h 96 h
MIVC (N) *
BTJ 601 ± 89 554 ± 75 545 ± 92 558 ± 94 579 ± 121 516 ± 101 558 ± 75
PLA 590 ± 123 541 ± 128 535 ± 120 544 ± 130 540 ± 126 509 ± 124 537 ± 122
hsCRP (mg·L−1)
BTJ 0.6 ± 0.72 0.61 ± 0.75 0.57 ± 0.69 0.64 ± 0.56 0.64 ± 0.58 0.52 ± 0.52 0.52 ± 0.49 0.46 ± 0.50 0.48 ± 0.50
PLA 0.44 ± 0.39 0.46 ± 0.45 0.44 ± 0.42 0.52 ± 0.52 0.4 ± 0.25 0.34 ± 0.21 0.35 ± 0.21 0.38 ± 0.22 0.38 ± 0.24
CK (IU·L−1) *
BTJ 188 ± 62 219 ± 68 383 ± 197 542 ± 461 406 ± 252 310 ± 145 349 ± 163 474 ± 246 516 ± 210
PLA 318 ± 145 362 ± 154 518 ± 274 592 ± 321 435 ± 255 387 ± 273 433 ± 290 623 ± 423 749 ± 423
LOOH (mmol·mL−1) *
BTJ 1.49 ± 0.25 1.68 ± 0.23 1.69 ± 0.37 1.33 ± 0.36 1.46 ± 0.19 1.47 ± 0.17 1.53 ± 0.40 1.74 ± 0.31 1.44 ± 0.21
PLA 1.53 ± 0.14 1.79 ± 0.23 1.77 ± 0.40 1.54 ± 0.16 1.57 ± 0.14 1.53 ± 0.12 1.69 ± 0.23 1.94 ± 0.75 1.44 ± 0.14
PC (µmol·L−1)
BTJ 14 ± 6 16 ± 0 15 ± 6 17 ± 5 18 ± 7 14 ± 5 16 ± 5 17 ± 10 15 ± 6
PLA 16 ± 8 19 ± 6 14 ± 6 13 ± 5 14 ± 5 18 ± 9 16 ± 7 15 ± 5 15 ± 4
A•− (AU)
BTJ 5567 ± 1898 6111 ± 2145 5883 ± 2044 6247 ± 1846 6202 ± 1911 5809 ± 2238 5752 ± 1854 5422 ± 2002 5862 ± 1802
PLA 6372 ± 1454 6730 ± 1337 6559 ± 2027 5674 ± 1716 5225 ± 1088 6013 ± 671 5433 ± 1521 6354 ± 1315 5819 ± 975
AU = Arbitrary unit; * denotes time effect (p < 0.05).
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4. Discussion
The main finding of the present study was that beetroot juice, when compared to a placebo, was
able to accelerate the recovery of CMJ and RI performance and reduce pain after a muscle-damaging
RST, but had no influence on sprint performance. Markers of systemic oxidative stress or other
biochemical indices associated with muscle damage were unaffected by beetroot juice supplementation.
In both the BTJ and PLA groups CMJ and RI significantly decreased after RST1, indicating the
presence of muscle damage; however, both CMJ and RI recovered quicker with BTJ (vs. PLA) during
the following +96 h (Figures 2 and 3, respectively). This was most evident at 72 h after the first sprint
bout (RST1), whereby CMJ and RI were still significantly lower than baseline values, but restored close
to pre-exercise values in BTJ group. These findings are consistent with our previous work, in which
we reported 3 days of BTJ supplementation enhanced the recovery of CMJ performance 72 h after
plyometric activity [19].
Interestingly, although BTJ appeared to enhance the recovery of the dynamic muscle function
(CMJ and RI), isometric strength (MIVC) was unaffected by BTJ supplementation. As previously
suggested [19], perhaps this discrepancy can be explained by the different movement patterns (i.e.,
static vs. dynamic function) and specific abilities each test measures (power vs. isometric strength).
Both CMJ and RI are arguably more ecologically valid tests of functional recovery than MIVC,
particularly for team-sports players as their movement patterns more closely reflect the activity
required for performance [35]. We initially hypothesized that sprint performance would be reduced in
RST2 compared to RST1; a consequence of muscle damage, and that this reduction would be attenuated
with BTJ supplementation. However, contrary to our hypothesis, aside from a non-significant decrease
in average sprint time (Table 3), sprint performance was largely unaffected in RST2 compared to RST1.
The reductions in muscle function were not different ≤24 h after both sprints tests though, suggesting
that the participants did not become accustomed to the sprint test after the first bout. Additionally, BTJ
had no influence on any aspect of sprint performance, although perhaps our ability to detect any
differences between groups was limited by the lack of change in performance between the two sprint
tests. Nonetheless, the fact that sprint performance was unchanged seems to contrast with other
studies who reported sprint times to still be slower than pre-exercise values up to 72 h after an RST
similar to the present study [36,41,42]. Because the muscle-damaging RST was fairly similar between
these studies (in fact, the one in the present study was designed to be more challenging), perhaps the
divergent findings between these studies and the present one is due, in large part, to the different
training status of the participants. The participants in the present study were experienced team-sports
players who regularly perform RSE as part of training and matches and, thus, may have been less
vulnerable to prolonged decrements in sprint performance than recreationally active participants
tested in some of the other studies [41,42].
In addition, the fact that CMJ and RI were still significantly depressed at 72 h post RST1, but
sprint performance was not, suggests that there is dissociation between these tests of dynamic muscle
function (CMJ and RI) and repeated sprint ability. Indeed, previous literature appears to be equivocal
on how well sprint and jump tests correlate. Some studies demonstrate that the time course of recovery
for CMJ and sprint performance are not different after muscle-damaging RSE [36,41,42], while others
agree with the present study [35,39,43], and have found that reductions in CMJ are more prolonged
than sprint decrements. A recent study attempted to address this issue by comparing CMJ, drop jumps
(DJ) and a 20 m sprint test after intermittent exercise and concluded that sprint performance seemed to
recover more rapidly than both CMJ and DJ performance, both of which were still below pre-exercise
values 72 h post-exercise [35]. This led the authors to suggest that CMJ and DJ are more sensitive
tests of prolonged changes in neuromuscular function, which could provide and explanation for the
dissociation between the jump and sprint tests in the present study.
Due to the fact that oxidative stress has been associated with muscle damage after eccentric-heavy
exercise [14,44], and that beetroot and its constituents have been shown to act as antioxidants [25,29],
we hypothesized that BTJ could attenuate muscle damage by protecting cells against oxidative stress.
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However, our findings do not support this contention. We found no evidence that BTJ attenuated
oxidative stress as both indirect markers (LOOH and PC) and a direct marker of free radical production
(A•−) were not different between the BTJ and PLA groups at all-time points (Table 5). These data are
in contrast to a number of previous studies that found antioxidant-rich food supplements reduced
oxidative stress after high intensity sprint exercise [14,45,46]. However, unlike these studies, we
did not find any evidence of oxidative stress throughout the trial, apart from an increase in LOOH
immediately post and 2.5 h post both sprint tests (Table 5). The modest increase in these markers
was unexpected, as previous studies reported large systemic elevations in oxidative stress up to 48 h
after high intensity intermittent cycling exercise [2,14] an activity which, in comparison to running,
typically results in less oxidative stress because of the absence of an extensive eccentric component [34].
The divergent findings in oxidative stress response between the present and aforementioned studies
could, therefore, be explained by the different biochemical markers examined and/or analytical
techniques used. Jowko and colleagues [14] for instance, noted systemic increases in total antioxidant
capacity (TAC), superoxide dismutase and glutathione peroxidase (GPX) 24 h after exercise and
Bogdanis and colleagues [2] noted increases in TAC, PC and GPX; thus, neither study measured LOOH
or A•− formation, as in the present study. Although this study and [2] both measured PC, different
analytical methods were used, which could account for the discrepant results. Nonetheless, EPR
spectroscopy is considered a valid and sensitive method for direct detection of excessive free radical
production [47,48], and the fact that we found no evidence of an increase in our data perhaps draws
into question the reliability of the indirect biomarkers in other studies using a similar protocol.
The fact that muscle damage was clearly evident in the days after both RST tests but oxidative
stress was not, suggests that muscle damage occurred independent of any systemic changes in
oxidative stress. This would perhaps suggest that ROS have a limited role in the muscle damage
process post-exercise. However, it cannot be ruled out that oxidative stress occurred, but was confined
predominately to muscle cells and surrounding tissues. Unfortunately, we did not measure muscle
samples in our study, and as such, this supposition is speculative. A recent review however, concluded
that skeletal muscle is a prime producer of ROS following exercise; so, intuitively, oxidative stress
would be expected to be greater in muscle than perhaps the circulation [49]. We recognize that the
inability to obtain muscle biopsy samples for oxidative stress measures could be considered a limitation
of this study. Alternatively, the muscle damage we observed could have been unrelated to oxidative
stress. Instead, the muscle damage could have been caused by other biochemical changes within
muscle, such as increased inflammation and calpain activity [50,51] or damage to components involved
in the excitation-contraction coupling pathway, as previously suggested [52].
Serum CK concentrations, incorporated as a surrogate marker of sarcolemma damage, were not
different in both groups after exercise (Table 5). The increase in CK after the RST was similar to previous
reports [3,42], as was the lack of a suppressive effect with an antioxidant-rich food beverage [19,23,45].
These data suggest that improved sarcolemma integrity cannot explain the enhanced rate of recovery
by BTJ in this study.
Because we found no changes in oxidative stress between groups, the beneficial effects of BTJ on
the recovery of CMJ and RI cannot be attributed to an antioxidant effect of the juice. This suggests
that mechanisms other than antioxidant effects were possibly involved. It was beyond the scope of
this study to examine the role of other mechanisms by which BTJ could attenuate muscle damage,
but owing to the seemingly pleotropic nature of phenolic and betalainic compounds and NO,
there are a number of possible candidates. For instance, other effects associated with phenolic
compounds and NO donors akin to BTJ are anti-inflammatory [25,33] and regenerative, in so far
as they appear to have a regulatory role in phagocytosis and promote satellite cell proliferation
in skeletal muscle [53–55]. Increasing in vivo NO availability has also demonstrated additional
biochemical effects that, conceivably, could contribute to improved functional recovery after exercise,
such as reduced calpain activity [56], increased muscle blood flow [57,58], and enhanced muscle
power potential, possibly via improved Ca2+ handing [59,60]. Thus, there are a number of potential
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mechanisms that could explain why BTJ supplementation was able to enhance the recovery of muscle
function, independent of antioxidant effects. However, since none of these mechanisms were measured
per se, we can only speculate the role, if any, that they may have had in the present study’s findings.
The potential role and their relative contributory effects require further exploration.
Participants in the BTJ group reported a significantly higher PPT than the PLA group 24 h after the
second sprint test (Figure 4). Reduced muscle pain when antioxidant-rich food supplements are taken
after muscle-damaging exercise has been reported by our group [19] and others [61]. The mechanism
by which BTJ might attenuate muscle pain is unclear however. Previous reports suggest that the
betalains in beetroot are responsible for its analgesic effects, most likely via an anti-inflammatory
related mechanism [26,62]. The possibility that an anti-inflammatory mechanism would be involved is
supported by data that suggests muscle pain after exercise may stem from the release of inflammatory
and noxious stimuli (i.e., bradykin and nerve growth factor) due to tears at the extracellular matrix [63,
64]. Perhaps BTJ acts to dampen inflammatory responses or desensitize pain receptors, as has been
suggested with ginger [65] and curcumin supplements [66]; however, whatever the precise mechanisms,
they are likely to occur at the skeletal muscle level.
It is also unclear why BTJ only improved PPT 24 h after RST2 in the present study and not at earlier
time points, as was shown in our earlier work [19]. A previous study did observe greater reductions
in pain scores after participants took betalain-rich beetroot supplements for 5–10 days compared to
1 day [26], which, coupled with our data, suggests that the analgesic effects of BTJ might be augmented
with longer-term dosage regimens. Such a possibility needs to be investigated in future studies.
In conclusion, this study demonstrates that consuming BTJ for 4 days after a muscle damaging
RST attenuated muscle pain and decrements in dynamic muscle function, as measured by CMJ and
RI. These effects did not translate to improved recovery of isometric strength or sprint performance
however. These data suggest BTJ could be applied as a post-exercise recovery strategy to attenuate
losses in some aspects of dynamic muscle function in team-sports players between bouts of repeated
sprint exercise; however, because sprint performance was unchanged, how transferable these findings
are to real-world team-sport competition is unclear. Future studies are needed to clarify the underlying
cellular mechanisms, as the beneficial effects of BTJ were shown to be unrelated to systemic changes in
oxidative stress or other biochemical markers of muscle damage.
Acknowledgments: The authors wish to thank all the participants for their hard work and commitment displayed
throughout testing.
Author Contributions: T.C., G.H., D.J.W., E.J.S. conceived and designed the experiments; T.C. and B.B. performed
the experiments; T.C. and B.B. analyzed the data; G.W.D. performed biochemical analysis; T.C., G.H., D.J.W., E.J.S.,
G.W.D. wrote the paper.
Conflicts of Interest: This study was funded as part of a doctoral degree that receives financial support from Gs
Fresh Ltd. The funders supplied the supplements used in this study but had no role in the conception of the study,
its design, preparation, analysis and writing of the manuscript. The authors declare no conflict of interest.
References
1. Girard, O.; Mendez-Villanueva, A.; Bishop, D. Repeated-sprint ability—Part I: Factors contributing to fatigue.
Sports Med. 2011, 41, 673–694. [CrossRef] [PubMed]
2. Bogdanis, G.C.; Stavrinou, P.; Fatouros, I.G.; Philippou, A.; Chatzinikolaou, A.; Draganidis, D.; Ermidis, G.;
Maridaki, M. Short-term high-intensity interval exercise training attenuates oxidative stress responses and
improves antioxidant status in healthy humans. Food Chem. Toxicol. 2013, 61, 171–177. [CrossRef] [PubMed]
3. Howatson, G.; Milak, A. Exercise-induced muscle damage following a bout of sport specific repeated sprints.
J. Strength Cond. Res. 2009, 23, 2419–2424. [CrossRef] [PubMed]
4. Duffield, R.; Cannon, J.; King, M. The effects of compression garments on recovery of muscle performance
following high-intensity sprint and plyometric exercise. J. Sci. Med. Sport 2010, 13, 136–140. [CrossRef]
[PubMed]
5. Howatson, G.; van Someren, K.A. The prevention and treatment of exercise-induced muscle damage.
Sports Med. 2008, 38, 483–503. [CrossRef] [PubMed]
Nutrients 2016, 8, 506 14 of 17
6. Mohr, M.; Draganidis, D.; Chatzinikolaou, A.; Barbero-Alvarez, J.C.; Castagna, C.; Douroudos, I.; Avloniti, A.;
Margeli, A.; Papassotiriou, I.; Flouris, A.D.; et al. Muscle damage, inflammatory, immune and performance
responses to three football games in 1 week in competitive male players. Eur. J. Appl. Physiol. 2016, 116,
179–193. [CrossRef] [PubMed]
7. Barnett, A. Using recovery modalities between training sessions in elite athletes—Does it help? Sports Med.
2006, 36, 781–796. [CrossRef] [PubMed]
8. Nedelec, M.; McCall, A.; Carling, C.; Legall, F.; Berthoin, S.; Dupont, G. Recovery in soccer: Part II—Ecovery
strategies. Sports Med. 2013, 43, 9–22. [CrossRef] [PubMed]
9. Clarkson, P.M.; Hubal, M.J. Exercise-induced muscle damage in humans. Am. J. Phys. Med. Rehabil. 2002, 81,
S52–S69. [CrossRef] [PubMed]
10. Hyldahl, R.D.; Hubal, M.J. Lengthening our perspective: Morphological, cellular, and molecular responses
to eccentric exercise. Muscle Nerve 2014, 49, 155–170. [CrossRef] [PubMed]
11. Brickson, S.; Ji, L.L.; Schell, K.; Olabisi, R.; St Pierre Schneider, B.; Best, T.M. M1/70 attenuates blood-borne
neutrophil oxidants, activation, and myofiber damage following stretch injury. J. Appl. Physiol. 2003, 95,
969–976. [CrossRef] [PubMed]
12. Pizza, F.X.; Peterson, J.M.; Baas, J.H.; Koh, T.J. Neutrophils contribute to muscle injury and impair its
resolution after lengthening contractions in mice. J. Physiol. 2005, 562, 899–913. [CrossRef] [PubMed]
13. Toumi, H.; Best, T.M. The inflammatory response: Friend or enemy for muscle injury? Br. J. Sports Med. 2003,
37, 284–286. [CrossRef] [PubMed]
14. Jowko, E.; Dlugolecka, B.; Makaruk, B.; Cieslinski, I. The effect of green tea extract supplementation on
exercise-induced oxidative stress parameters in male sprinters. Eur. J. Nutr. 2015, 54, 783–791. [CrossRef]
[PubMed]
15. Bailey, D.M.; Williams, C.; Betts, J.A.; Thompson, D.; Hurst, T.L. Oxidative stress, inflammation and recovery
of muscle function after damaging exercise: Effect of 6-week mixed antioxidant supplementation. Eur. J.
Appl. Physiol. 2011, 111, 925–936. [CrossRef] [PubMed]
16. Nikolaidis, M.G.; Kerksick, C.M.; Lamprecht, M.; McAnulty, S.R. Does vitamin C and E supplementation
impair the favorable adaptations of regular exercise? Oxid. Med. Cell. Longev. 2012, 2012, 707941. [CrossRef]
[PubMed]
17. Close, G.L.; Ashton, T.; Cable, T.; Doran, D.; Holloway, C.; McArdle, F.; MacLaren, D.P. Ascorbic acid
supplementation does not attenuate post-exercise muscle soreness following muscle-damaging exercise but
may delay the recovery process. Br. J. Nutr. 2006, 95, 976–981. [CrossRef] [PubMed]
18. Sousa, M.; Teixeira, V.H.; Soares, J. Dietary strategies to recover from exercise-induced muscle damage. Int. J.
Food Sci. Nutr. 2014, 65, 151–163. [CrossRef] [PubMed]
19. Clifford, T.; Bell, O.; West, D.J.; Howatson, G.; Stevenson, E.J. The effects of beetroot juice supplementation
on indices of muscle damage following eccentric exercise. Eur. J. Appl. Physiol. 2016, 116, 353–362. [CrossRef]
[PubMed]
20. Clifford, T.; Constantinou, C.M.; Keane, K.M.; West, D.J.; Howatson, G.; Stevenson, E.J. The plasma
bioavailability of nitrate and betanin from beta vulgaris rubra in humans. Eur. J. Nutr. 2016. [CrossRef]
[PubMed]
21. Wootton-Beard, P.C.; Moran, A.; Ryan, L. Stability of the total antioxidant capacity and total polyphenol
content of 23 commercially available vegetable juices before and after in vitro digestion measured by frap,
dpph, abts and folin–ciocalteu methods. Food Res. Int. 2011, 44, 217–224. [CrossRef]
22. Ryan, L.; Prescott, S.L. Stability of the antioxidant capacity of twenty-five commercially available fruit juices
subjected to an in vitro digestion. Int. J. Food Sci. Technol. 2010, 45, 1191–1197. [CrossRef]
23. Howatson, G.; McHugh, M.P.; Hill, J.A.; Brouner, J.; Jewell, A.P.; van Someren, K.A.; Shave, R.E.;
Howatson, S.A. Influence of tart cherry juice on indices of recovery following marathon running. Scand. J.
Med. Sci. Sports 2010, 20, 843–852. [CrossRef] [PubMed]
24. Seeram, N.P.; Aviram, M.; Zhang, Y.; Henning, S.M.; Feng, L.; Dreher, M.; Heber, D. Comparison of
antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J. Agric.
Food Chem. 2008, 56, 1415–1422. [CrossRef] [PubMed]
Nutrients 2016, 8, 506 15 of 17
25. El Gamal, A.A.; AlSaid, M.S.; Raish, M.; Al-Sohaibani, M.; Al-Massarani, S.M.; Ahmad, A.;
Hefnawy, M.; Al-Yahya, M.; Basoudan, O.A.; Rafatullah, S. Beetroot (Beta vulgaris L.) extract ameliorates
Gentamicin-induced nephrotoxicity associated oxidative stress, inflammation, and apoptosis in rodent
model. Mediat. Inflamm. 2014, 2014, 983952. [CrossRef] [PubMed]
26. Pietrzkowski, Z.; Nemzer, B.; Spórna, A.; Stalica, P.; Tresher, W.; Keller, R.; Jimenez, R.; Michałowski, T.;
Wybraniec, S. Influence of betalain-rich extract on reduction of discomfort associated with osteoarthritis.
New Med. 2010, 1, 12–17.
27. Vulic, J.J.; Cebovic, T.N.; Canadanovic, V.M.; Cetkovic, G.S.; Djilas, S.M.; Canadanovic-Brunet, J.M.;
Velicanski, A.S.; Cvetkovic, D.D.; Tumbas, V.T. Antiradical, antimicrobial and cytotoxic activities of
commercial beetroot pomace. Food Funct. 2013, 4, 713–721. [CrossRef] [PubMed]
28. Wootton-Beard, P.C.; Ryan, L. A beetroot juice shot is a significant and convenient source of bioaccessible
antioxidants. J. Funct. Foods 2011, 3, 329–334. [CrossRef]
29. Esatbeyoglu, T.; Wagner, A.E.; Motafakkerazad, R.; Nakajima, Y.; Matsugo, S.; Rimbach, G. Free radical
scavenging and antioxidant activity of betanin: Electron spin resonance spectroscopy studies and studies in
cultured cells. Food Chem. Toxicol. 2014, 73, 119–126. [CrossRef] [PubMed]
30. Esatbeyoglu, T.; Wagner, A.E.; Schini-Kerth, V.B.; Rimbach, G. Betanin-a food colorant with biological activity.
Mol. Nutr. Food Res. 2015, 59, 36–47. [CrossRef] [PubMed]
31. Krajka-Kuzniak, V.; Paluszczak, J.; Szaefer, H.; Baer-Dubowska, W. Betanin, a beetroot component, induces
nuclear factor erythroid-2-related factor 2-mediated expression of detoxifying/antioxidant enzymes in
human liver cell lines. Br. J. Nutr. 2013, 110, 2138–2149. [CrossRef] [PubMed]
32. Szaefer, H.; Krajka-Kuzniak, V.; Ignatowicz, E.; Adamska, T.; Baer-Dubowska, W. Evaluation of the effect
of beetroot juice on DMBA-induced damage in liver and mammary gland of female sprague-dawley rats.
Phytother. Res. 2014, 28, 55–61. [CrossRef] [PubMed]
33. Jadert, C.; Petersson, J.; Massena, S.; Ahl, D.; Grapensparr, L.; Holm, L.; Lundberg, J.O.; Phillipson, M.
Decreased leukocyte recruitment by inorganic nitrate and nitrite in microvascular inflammation and
nsaid-induced intestinal injury. Free Radic. Biol. Med. 2012, 52, 683–692. [CrossRef] [PubMed]
34. Nikolaidis, M.G.; Jamurtas, A.Z.; Paschalis, V.; Fatouros, I.G.; Koutedakis, Y.; Kouretas, D. The effect of
muscle-damaging exercise on blood and skeletal muscle oxidative stress: Magnitude and time-course
considerations. Sports Med. 2008, 38, 579–606. [CrossRef] [PubMed]
35. Gathercole, R.J.; Sporer, B.C.; Stellingwerff, T.; Sleivert, G.G. Comparison of the capacity of different jump
and sprint field tests to detect neuromuscular fatigue. J. Strength Cond. Res. 2015, 29, 2522–2531. [CrossRef]
[PubMed]
36. Keane, K.M.; Salicki, R.; Goodall, S.; Thomas, K.; Howatson, G. Muscle damage response in female collegiate
athletes after repeated sprint activity. J. Strength Cond. Res. 2015, 29, 2802–2807. [CrossRef] [PubMed]
37. Lakomy, J.; Haydon, D.T. The effects of enforced, rapid deceleration on performance in a multiple sprint test.
J. Strength Cond. Res. 2004, 18, 579–583. [CrossRef] [PubMed]
38. Thompson, D.; Nicholas, C.W.; Williams, C. Muscular soreness following prolonged intermittent
high-intensity shuttle running. J. Sports Sci. 1999, 17, 387–395. [CrossRef] [PubMed]
39. Andersson, H.; Raastad, T.; Nilsson, J.; Paulsen, G.; Garthe, I.; Kadi, F. Neuromuscular fatigue and recovery
in elite female soccer: Effects of active recovery. Med. Sci. Sports Exerc. 2008, 40, 372–380. [CrossRef]
[PubMed]
40. Cockburn, E.; Robson-Ansley, P.; Hayes, P.R.; Stevenson, E. Effect of volume of milk consumed on the
attenuation of exercise-induced muscle damage. Eur. J. Appl. Physiol. 2012, 112, 3187–3194. [CrossRef]
[PubMed]
41. Brown, M.A.; Howatson, G.; Keane, K.; Stevenson, E.J. Exercise-induced muscle damage following dance
and sprint specific exercise in females. J. Sports Med. Phys. Fit. 2015, in press.
42. Woolley, B.P.; Jakeman, J.R.; Faulkner, J.A. Multiple sprint exercise with a short deceleration induces muscle
damage and performance impairment in young, physically active males. J. Athl. Enhanc. 2014, 3. [CrossRef]
43. Semark, A.; Noakes, T.D.; St Clair Gibson, A.; Lambert, M.I. The effect of a prophylactic dose of flurbiprofen
on muscle soreness and sprinting performance in trained subjects. J. Sports Sci. 1999, 17, 197–203. [CrossRef]
[PubMed]
Nutrients 2016, 8, 506 16 of 17
44. Close, G.L.; Ashton, T.; Cable, T.; Doran, D.; MacLaren, D.P. Eccentric exercise, isokinetic muscle torque and
delayed onset muscle soreness: The role of reactive oxygen species. Eur. J. Appl. Physiol. 2004, 91, 615–621.
[CrossRef] [PubMed]
45. Bell, P.G.; Walshe, I.H.; Davison, G.W.; Stevenson, E.; Howatson, G. Montmorency cherries reduce the
oxidative stress and inflammatory responses to repeated days high-intensity stochastic cycling. Nutrients
2014, 6, 829–843. [CrossRef] [PubMed]
46. Goldfarb, A.H.; Garten, R.S.; Cho, C.; Chee, P.D.; Chambers, L.A. Effects of a fruit/berry/vegetable
supplement on muscle function and oxidative stress. Med. Sci. Sports Exerc. 2011, 43, 501–508. [CrossRef]
[PubMed]
47. Buettner, G.R.; Jurkiewicz, B.A. Ascorbate free-radical as a marker of oxidative stress—An EPR study.
Free Radic. Biol. Med. 1993, 14, 49–55. [CrossRef]
48. Pietri, S.; Seguin, J.R.; Darbigny, P.; Culcasi, M. Ascorbyl free-radical—A noninvasive marker of oxidative
stress in human open-heart-surgery. Free Radic. Biol. Med. 1994, 16, 523–528. [CrossRef]
49. Jackson, M.J.; Vasilaki, A.; McArdle, A. Cellular mechanisms underlying oxidative stress in human exercise.
Free Radic. Biol. Med. 2016, 98, 13–17. [CrossRef] [PubMed]
50. Belcastro, A.N.; Shewchuk, L.D.; Raj, D.A. Exercise-induced muscle injury: A calpain hypothesis.
Mol. Cell. Biochem. 1998, 179, 135–145. [CrossRef] [PubMed]
51. Paulsen, G.R.; Benestad, H.B.; Strom-Gundersen, I.; Morkrid, L.; Lappegard, K.T.; Raastad, T. Delayed
leukocytosis and cytokine response to high-force eccentric exercise. Med. Sci. Sports Exerc. 2005, 37,
1877–1883. [CrossRef] [PubMed]
52. Warren, G.L.; Ingalls, C.P.; Lowe, D.A.; Armstrong, R.B. What mechanisms contribute to the strength loss
that occurs during and in the recovery from skeletal muscle injury? J. Orthop. Sports Phys. Ther. 2002, 32,
58–64. [CrossRef] [PubMed]
53. Rigamonti, E.; Touvier, T.; Clementi, E.; Manfredi, A.A.; Brunelli, S.; Rovere-Querini, P. Requirement of
inducible nitric oxide synthase for skeletal muscle regeneration after acute damage. J. Immunol. 2013, 190,
1767–1777. [CrossRef] [PubMed]
54. Sakurai, T.; Kashimura, O.; Kano, Y.; Ohno, H.; Ji, L.L.; Izawa, T.; Best, T.M. Role of nitric oxide in muscle
regeneration following eccentric muscle contractions in rat skeletal muscle. J. Physiol. Sci. 2013, 63, 263–270.
[CrossRef] [PubMed]
55. Kruger, M.J.; Smith, C. Postcontusion polyphenol treatment alters inflammation and muscle regeneration.
Med. Sci. Sports Exerc. 2012, 44, 872–880. [CrossRef] [PubMed]
56. Lomonosova, Y.N.; Shenkman, B.S.; Kalamkarov, G.R.; Kostrominova, T.Y.; Nemirovskaya, T.L. L-arginine
supplementation protects exercise performance and structural integrity of muscle fibers after a single bout
of eccentric exercise in rats. PLoS ONE 2014, 9, e94448. [CrossRef] [PubMed]
57. Ferguson, S.K.; Holdsworth, C.T.; Wright, J.L.; Fees, A.J.; Allen, J.D.; Jones, A.M.; Musch, T.I.; Poole, D.C.
Microvascular oxygen pressures in muscles comprised of different fiber types: Impact of dietary nitrate
supplementation. Nitric Oxide 2015, 48, 38–43. [CrossRef] [PubMed]
58. Ferguson, S.K.; Hirai, D.M.; Copp, S.W.; Holdsworth, C.T.; Allen, J.D.; Jones, A.M.; Musch, T.I.; Poole, D.C.
Effects of nitrate supplementation via beetroot juice on contracting rat skeletal muscle microvascular oxygen
pressure dynamics. Respir. Physiol. Neurobiol. 2013, 187, 250–255. [CrossRef] [PubMed]
59. Hernandez, A.; Schiffer, T.A.; Ivarsson, N.; Cheng, A.J.; Bruton, J.D.; Lundberg, J.O.; Weitzberg, E.;
Westerblad, H. Dietary nitrate increases tetanic [ca2+]i and contractile force in mouse fast-twitch muscle.
J. Physiol. 2012, 590, 3575–3583. [CrossRef] [PubMed]
60. Coggan, A.R.; Leibowitz, J.L.; Kadkhodayan, A.; Thomas, D.P.; Ramamurthy, S.; Spearie, C.A.; Waller, S.;
Farmer, M.; Peterson, L.R. Effect of acute dietary nitrate intake on maximal knee extensor speed and power
in healthy men and women. Nitric Oxide 2015, 48, 16–21. [CrossRef] [PubMed]
61. Connolly, D.A.; McHugh, M.P.; Padilla-Zakour, O.I.; Carlson, L.; Sayers, S.P. Efficacy of a tart cherry juice
blend in preventing the symptoms of muscle damage. Br. J. Sports Med. 2006, 40, 679–683. [CrossRef]
[PubMed]
62. Reyes-Izquierdo, T.; Pietrzkowski, Z.; Argumedo, R.; Shu, C.; Nemzer, B.; Wybraniec, S. Betalain-rich red
beet concentrate improves reduced knee discomfort and joint function: A double blind, placebo-controlled
pilot clinical study. Nutr. Diet. Suppl. 2014, 2014, 9–10. [CrossRef]
Nutrients 2016, 8, 506 17 of 17
63. Crameri, R.M.; Aagaard, P.; Qvortrup, K.; Langberg, H.; Olesen, J.; Kjaer, M. Myofibre damage in human
skeletal muscle: Effects of electrical stimulation versus voluntary contraction. J. Physiol. 2007, 583, 365–380.
[CrossRef] [PubMed]
64. Murase, S.; Terazawa, E.; Queme, F.; Ota, H.; Matsuda, T.; Hirate, K.; Kozaki, Y.; Katanosaka, K.; Taguchi, T.;
Urai, H.; et al. Bradykinin and nerve growth factor play pivotal roles in muscular mechanical hyperalgesia
after exercise (delayed-onset muscle soreness). J. Neurosci. 2010, 30, 3752–3761. [CrossRef] [PubMed]
65. Wilson, P.B. Ginger (zingiber officinale) as an analgesic and ergogenic aid in sport: A systemic review.
J. Strength Cond. Res. 2015, 29, 2980–2995. [CrossRef] [PubMed]
66. Drobnic, F.; Riera, J.; Appendino, G.; Togni, S.; Franceschi, F.; Valle, X.; Pons, A.; Tur, J. Reduction of delayed
onset muscle soreness by a novel curcumin delivery system (meriva®): A randomised, placebo-controlled
trial. J. Int. Soc. Sports Nutr. 2014, 11, 31. [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
